Commonwealth Equity Services’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
Other funds holding TVRD
DGI
C
FCM
Commonwealth Equity Services's TVRD Position: Q2 2024 in Review
Commonwealth Equity Services sold out of Tvardi Therapeutics (TVRD) in Q2 2024, closing a stake of 342 shares — an estimated $11K sold.
Commonwealth Equity Services first reported a position in TVRD in Q1 2017 and held it in 16 quarters. The position peaked at $532K in Q3 2017. 79 funds tracked by Wall St. Rank hold TVRD as of Q2 2024.
- Commonwealth Equity Services reported no remaining Tvardi Therapeutics position as of Q2 2024 after selling out during the quarter.
- Commonwealth Equity Services sold 342 Tvardi Therapeutics shares in Q2 2024, an estimated $11K.
- Commonwealth Equity Services first reported a position in Tvardi Therapeutics in Q1 2017 and held it in 16 quarters.
- Commonwealth Equity Services's Tvardi Therapeutics position peaked at $532K in Q3 2017.
- 79 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2024.
Based on Commonwealth Equity Services's 13F filing for Q2 2024, filed 31 Jul 2024.